company background image
DXR

Daxor NasdaqCM:DXR Stock Report

Last Price

US$9.55

Market Cap

US$40.7m

7D

-1.5%

1Y

-13.1%

Updated

01 Dec, 2022

Data

Company Financials
DXR fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health3/6
Dividends0/6

DXR Stock Overview

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing.

Daxor Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Daxor
Historical stock prices
Current Share PriceUS$9.55
52 Week HighUS$14.55
52 Week LowUS$9.01
Beta-0.83
1 Month Change-18.37%
3 Month Change-27.79%
1 Year Change-13.14%
3 Year Change-0.66%
5 Year Change80.19%
Change since IPO163.45%

Recent News & Updates

Recent updates

Daxor's (NASDAQ:DXR) Earnings Aren't As Good As They Appear

Mar 08
Daxor's (NASDAQ:DXR) Earnings Aren't As Good As They Appear

A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)

Feb 27
A Look At The Fair Value Of Daxor Corporation (NYSEMKT:DXR)

Shareholder Returns

DXRUS Medical EquipmentUS Market
7D-1.5%1.8%1.5%
1Y-13.1%-16.8%-14.8%

Return vs Industry: DXR exceeded the US Medical Equipment industry which returned -16.8% over the past year.

Return vs Market: DXR exceeded the US Market which returned -14.8% over the past year.

Price Volatility

Is DXR's price volatile compared to industry and market?
DXR volatility
DXR Average Weekly Movement7.5%
Medical Equipment Industry Average Movement8.8%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: DXR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: DXR's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1971n/aMichael Feldschuhhttps://www.daxor.com

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973.

Daxor Corporation Fundamentals Summary

How do Daxor's earnings and revenue compare to its market cap?
DXR fundamental statistics
Market CapUS$40.71m
Earnings (TTM)US$4.48m
Revenue (TTM)US$287.68k

9.1x

P/E Ratio

141.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DXR income statement (TTM)
RevenueUS$287.68k
Cost of RevenueUS$0
Gross ProfitUS$287.68k
Other Expenses-US$4.20m
EarningsUS$4.48m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.05
Gross Margin100.00%
Net Profit Margin1,558.79%
Debt/Equity Ratio14.3%

How did DXR perform over the long term?

See historical performance and comparison